These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33203843)

  • 1. Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.
    Liu Q; Zaba LC; Satpathy AT; Longmire M; Zhang W; Li K; Granja J; Guo C; Lin J; Li R; Tolentino K; Kania G; Distler O; Fiorentino D; Chung L; Qu K; Chang HY
    Nat Commun; 2020 Nov; 11(1):5843. PubMed ID: 33203843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis.
    Huang M; Tabib T; Khanna D; Assassi S; Domsic R; Lafyatis R
    Ann Rheum Dis; 2024 Sep; 83(10):1335-1344. PubMed ID: 38754983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadening our understanding of genetic risk for scleroderma/systemic sclerosis by querying the chromatin architecture surrounding the risk haplotypes.
    Poppenberg KE; Tutino VM; Tarbell E; Jarvis JN
    BMC Med Genomics; 2021 Apr; 14(1):114. PubMed ID: 33894768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma.
    Miura S; Watanabe Y; Saigusa R; Yamashita T; Nakamura K; Hirabayashi M; Miyagawa T; Yoshizaki A; Trojanowska M; Sato S; Asano Y
    Arthritis Res Ther; 2021 May; 23(1):137. PubMed ID: 33964960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.
    Papazoglou A; Huang M; Bulik M; Lafyatis A; Tabib T; Morse C; Sembrat J; Rojas M; Valenzi E; Lafyatis R
    Arthritis Rheumatol; 2022 Dec; 74(12):2003-2014. PubMed ID: 35849803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin.
    Tsou PS; Palisoc PJ; Ali M; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2021 Aug; 73(8):1501-1513. PubMed ID: 33586346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
    Affandi AJ; Carvalheiro T; Ottria A; Broen JC; Bossini-Castillo L; Tieland RG; Bon LV; Chouri E; Rossato M; Mertens JS; Garcia S; Pandit A; de Kroon LM; Christmann RB; Martin J; van Roon JA; Radstake TR; Marut W
    Ann Rheum Dis; 2019 Sep; 78(9):1249-1259. PubMed ID: 31126957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in scleroderma.
    Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Sato S; Kadono T
    J Dermatol Sci; 2020 Feb; 97(2):125-134. PubMed ID: 31959382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis.
    Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q
    J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration.
    de-Sá-Earp AP; do Nascimento AP; Carneiro SC; Porto LC; Monte-Alto-Costa A
    Am J Dermatopathol; 2013 Jun; 35(4):438-44. PubMed ID: 23262669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
    Asano Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.
    Gourh P; Agarwal SK; Divecha D; Assassi S; Paz G; Arora-Singh RK; Reveille JD; Shete S; Mayes MD; Arnett FC; Tan FK
    Arthritis Rheum; 2009 Dec; 60(12):3794-806. PubMed ID: 19950257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
    Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
    J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome bisulfite sequencing in systemic sclerosis provides novel targets to understand disease pathogenesis.
    Lu T; Klein KO; Colmegna I; Lora M; Greenwood CMT; Hudson M
    BMC Med Genomics; 2019 Oct; 12(1):144. PubMed ID: 31651337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
    Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis.
    Manetti M; Allanore Y; Saad M; Fatini C; Cohignac V; Guiducci S; Romano E; Airó P; Caramaschi P; Tinazzi I; Riccieri V; Della Rossa A; Abbate R; Caporali R; Cuomo G; Valesini G; Dieudé P; Hachulla E; Cracowski JL; Tiev K; Letenneur L; Amouyel P; Lambert JC; Chiocchia G; Martinez M; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1034-41. PubMed ID: 22402147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
    Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.
    Zhao W; Yue X; Liu K; Zheng J; Huang R; Zou J; Riemekasten G; Petersen F; Yu X
    Rheumatol Int; 2017 Aug; 37(8):1303-1310. PubMed ID: 28434122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?
    Asano Y; Takahashi T; Saigusa R
    J Dermatol Sci; 2019 May; 94(2):259-265. PubMed ID: 31079997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.